Case and research letter
Oral Hyperpigmentation Associated With Interferon-Alpha and Ribavirin Therapy for Hepatitis C Virus Infection
Pigmentación oral asociada al tratamiento con alfa-interferón y ribavirina para la hepatitis C
J. Marcoval
, J. Notario, C. Martín, S. Gómez
Autor para correspondencia
Servicio de Dermatología, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain
Leído
9429
Vecesse ha leído el artículo
2422
Total PDF
7007
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 33 | 6 | 39 |
| 2025 5 | 206 | 36 | 242 |
| 2025 4 | 225 | 33 | 258 |
| 2025 3 | 191 | 28 | 219 |
| 2025 2 | 155 | 46 | 201 |
| 2025 1 | 78 | 38 | 116 |
| 2024 12 | 106 | 32 | 138 |
| 2024 11 | 130 | 78 | 208 |
| 2024 10 | 115 | 59 | 174 |
| 2024 9 | 76 | 35 | 111 |
| 2024 8 | 107 | 84 | 191 |
| 2024 7 | 77 | 36 | 113 |
| 2024 6 | 74 | 29 | 103 |
| 2024 5 | 73 | 37 | 110 |
| 2024 4 | 85 | 24 | 109 |
| 2024 3 | 86 | 31 | 117 |
| 2024 2 | 72 | 27 | 99 |
| 2024 1 | 63 | 36 | 99 |
| 2023 12 | 46 | 20 | 66 |
| 2023 11 | 60 | 30 | 90 |
| 2023 10 | 68 | 33 | 101 |
| 2023 9 | 64 | 43 | 107 |
| 2023 8 | 59 | 22 | 81 |
| 2023 7 | 75 | 32 | 107 |
| 2023 6 | 50 | 26 | 76 |
| 2023 5 | 68 | 20 | 88 |
| 2023 4 | 49 | 25 | 74 |
| 2023 3 | 49 | 25 | 74 |
| 2023 2 | 55 | 20 | 75 |
| 2022 1 | 53 | 39 | 92 |
| 2022 12 | 67 | 42 | 109 |
| 2022 11 | 35 | 26 | 61 |
| 2022 10 | 40 | 20 | 60 |
| 2022 9 | 30 | 40 | 70 |
| 2022 8 | 17 | 34 | 51 |
| 2022 7 | 23 | 30 | 53 |
| 2022 6 | 28 | 29 | 57 |
| 2022 5 | 49 | 29 | 78 |
| 2022 4 | 78 | 31 | 109 |
| 2022 3 | 100 | 40 | 140 |
| 2022 2 | 43 | 18 | 61 |
| 2021 1 | 48 | 31 | 79 |
| 2021 12 | 52 | 33 | 85 |
| 2021 11 | 56 | 41 | 97 |
| 2021 10 | 66 | 48 | 114 |
| 2021 9 | 48 | 40 | 88 |
| 2021 8 | 52 | 28 | 80 |
| 2021 7 | 47 | 26 | 73 |
| 2021 6 | 45 | 28 | 73 |
| 2021 5 | 43 | 38 | 81 |
| 2021 4 | 70 | 26 | 96 |
| 2021 3 | 57 | 22 | 79 |
| 2021 2 | 57 | 16 | 73 |
| 2020 1 | 37 | 10 | 47 |
| 2020 12 | 38 | 14 | 52 |
| 2020 11 | 20 | 8 | 28 |
| 2020 10 | 28 | 10 | 38 |
| 2020 9 | 32 | 15 | 47 |
| 2020 8 | 17 | 10 | 27 |
| 2020 7 | 35 | 10 | 45 |
| 2020 6 | 26 | 18 | 44 |
| 2020 5 | 20 | 12 | 32 |
| 2020 4 | 32 | 19 | 51 |
| 2020 3 | 29 | 23 | 52 |
| 2020 2 | 3 | 6 | 9 |
| 2020 1 | 2 | 12 | 14 |
| 2019 12 | 8 | 1 | 9 |
| 2019 11 | 4 | 0 | 4 |
| 2019 9 | 8 | 1 | 9 |
| 2019 8 | 2 | 1 | 3 |
| 2019 7 | 6 | 10 | 16 |
| 2019 6 | 6 | 14 | 20 |
| 2019 5 | 5 | 17 | 22 |
| 2019 4 | 2 | 19 | 21 |
| 2019 3 | 2 | 8 | 10 |
| 2019 2 | 6 | 0 | 6 |
| 2019 1 | 2 | 3 | 5 |
| 2018 12 | 0 | 3 | 3 |
| 2018 11 | 2 | 4 | 6 |
| 2018 10 | 3 | 0 | 3 |
| 2018 9 | 5 | 3 | 8 |
| 2018 5 | 0 | 1 | 1 |
| 2018 3 | 28 | 1 | 29 |
| 2018 2 | 95 | 5 | 100 |
| 2018 1 | 126 | 2 | 128 |
| 2017 12 | 89 | 5 | 94 |
| 2017 11 | 65 | 10 | 75 |
| 2017 10 | 58 | 3 | 61 |
| 2017 9 | 62 | 5 | 67 |
| 2017 8 | 91 | 9 | 100 |
| 2017 7 | 67 | 7 | 74 |
| 2017 6 | 82 | 22 | 104 |
| 2017 5 | 83 | 16 | 99 |
| 2017 4 | 116 | 8 | 124 |
| 2017 3 | 81 | 23 | 104 |
| 2017 2 | 70 | 19 | 89 |
| 2016 1 | 53 | 5 | 58 |
| 2016 12 | 65 | 13 | 78 |
| 2016 11 | 117 | 6 | 123 |
| 2016 10 | 116 | 11 | 127 |
| 2016 9 | 187 | 9 | 196 |
| 2016 8 | 161 | 8 | 169 |
| 2016 7 | 71 | 7 | 78 |
| 2016 6 | 15 | 4 | 19 |
| 2016 5 | 6 | 5 | 11 |
| 2016 4 | 6 | 16 | 22 |
| 2016 3 | 3 | 22 | 25 |
| 2016 2 | 7 | 18 | 25 |
| 2015 1 | 13 | 14 | 27 |
| 2015 12 | 3 | 13 | 16 |
| 2015 11 | 8 | 12 | 20 |
| 2015 10 | 8 | 4 | 12 |
| 2015 9 | 6 | 41 | 47 |
| 2015 8 | 4 | 2 | 6 |
| 2015 7 | 130 | 11 | 141 |
| 2015 6 | 60 | 1 | 61 |
| 2015 5 | 60 | 4 | 64 |
| 2015 4 | 62 | 12 | 74 |
| 2015 3 | 76 | 3 | 79 |
| 2015 2 | 60 | 4 | 64 |
| 2015 1 | 54 | 1 | 55 |
| 2014 12 | 54 | 4 | 58 |
| 2014 11 | 48 | 4 | 52 |
| 2014 10 | 40 | 3 | 43 |
| 2014 9 | 43 | 1 | 44 |
| 2014 8 | 36 | 8 | 44 |
| 2014 7 | 33 | 5 | 38 |
| 2014 6 | 42 | 4 | 46 |
| 2014 5 | 34 | 6 | 40 |
| 2014 4 | 14 | 3 | 17 |
| 2014 3 | 20 | 5 | 25 |
Mostrar todo
